Jessica Johnson: As our team watches these trends, we can see that counterfeit GLP-1s are not limited to when the drug is in shortage, but the shortage of legitimate GLP-1 drugs has increased the number of counterfeit GLP-1-related cases
Research using these peptides must adhere to appropriate institutional review and safety protocols including proper handling procedures, waste disposal, and experimental design safeguards
Similar results were obtained in models of medial collateral ligament and quadriceps injuries
GLP-1 receptor agonists (GLP-1-RA) were first developed for the treatment of type-2 diabetes, but have been recently approved for treatment of obesity
[Abstract]2024 Feb 12;33(11):2585-2596
(PubMed) Levine M, Conry-Cantilena C, Wang Y, et al